SAN DIEGO (AP) — SAN DIEGO (AP) — Neurocrine Biosciences Inc. (NBIX) on Tuesday reported third-quarter net income of $83.1 million.
On a per-share basis, the San Diego-based company said it had net income of 82 cents.
The results missed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of 91 cents per share.
The biopharmaceutical company posted revenue of $498.8 million in the period, which topped Street forecasts. Eleven analysts surveyed by Zacks expected $479.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NBIX at https://www.zacks.com/ap/NBIX
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
